photo walkheader_zpsd5bunpmi.png

Category Archives: Pancreatic Cancer Medical Treatment

MiRNAs Acting in Concert Impede PDCD4 and Related Genes in Pancreatic Cancer

Writing a pancreatic cancer blog is interesting. Research questions seem limited only by the level of imagination of researchers. We have addressed in our Pancreatica Blog a small body of research related to MicroRNA (MiRNA) work primarily related to seeking patterns that may aid in the eventual earlier diagnosis or even screening for pancreatic cancer […]

Daniel Von Hoff Inducted into Lederberg Society for Work on Abraxane in Pancreatic Cancer

One of our favorite physician pancreatic cancer researchers, Daniel Von Hoff, has been honored by induction into the Joshua Lederberg Society on February 13, 2014 primarily for his work in shepherding the development of Abraxane (nab-paclitaxel) in combination with gemcitabine for the treatment of advanced cancer of the pancreas (ductal adenocarcinoma of the pancreas). This […]

MORE STROMA: Inhibiting Fibroblast Growth Factor Disrupts Pancreatic Cancer Cell Invasion

As mentioned, stromal tissue can account for as much as 90% of the bulk in pancreatic cancer tumors (ductal adenocarcinoma of the pancreas). Thought in the past to have been relatively inert, it is increasingly clear that this dense tissue arising from a desmoplastic process is surprisingly dynamic. Thus, it is heartening to encounter a […]

Page 6 of 12« First...45678...Last »
Facebook
Facebook